Current recommendations for diagnosis and management of polyoma BK virus nephropathy in renal transplant recipients

Nephrology Dialysis Transplantation

Volumn 21, Issue 12, 2006, Pages 3364-3367

  Blanckaert, Katrien ^a   De Vriese, An S ^a  

^a Renal Unit   (Belgium)

Author keywords

Nephropathy; Polyoma BK virus; Transplantation

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CIDOFOVIR; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PROBENECID; RIBAVIRIN; TSUKUBAENOLIDE; VIDARABINE;

ACUTE GRAFT REJECTION; BK VIRUS; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY GRAFT; MAINTENANCE DRUG DOSE; NEPHROTOXICITY; NONHUMAN; NOTE; PATIENT IDENTIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; VIRUS REACTIVATION;

BK VIRUS; HUMANS; KIDNEY TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; PRACTICE GUIDELINES; TUMOR VIRUS INFECTIONS;

EID: 33751433635     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl404     Document Type: Note

References (29)

1. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611-623
2. Brennan DC, Agha I, Bohl DL et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582-594
3. Trofe J, Gaber LW, Stratta RJ et al. Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis 2003; 5: 21-28
4. Hirsch HH, Brennan DC, Drachenberg CB et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277-1286
5. Ramos E, Drachenberg CB, Papadimitriou JC et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145-2151
6. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal transplant recipients. N Engl J Med 2002; 347: 488-496
7. Drachenberg C, Hirsch HH, Papadimitriou JC et al. Cost efficiency in the prospective diagnosis and follow-up of polyomavirus allograft nephropathy. Transplant Proc 2004; 36: 3028-3031
8. Randhawa P, Ho A, Shapiro R et al. Correlates of quantitative measurement of BK Polyomavirus (BKV) DNA with clinical course or BKV infection in renal transplant recipients. J Clin Microbiol 2004; 42: 1176-1180
9. Binet I, Nickeleit V, Hirsch HH et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918-922
10. Howell DN, Smith SR, Butterly DW et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation 1999; 68: 1279-1288
11. Barri YM, Ahmad I, Ketel BL et al. Polyoma viral infection in renal transplantation: The role of immunosuppressive therapy. Clin Transplant 2001; 15: 240-246
12. Kuypers DRJ, Vandooren AK, Lerut E et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005; 5: 1997-2004
13. Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-109
14. Williams JW, Mital D, Chong A et al. Experiences with leflunomide in solid organ transplantation. Transplantation 2002; 73: 358-366
15. Josephson MA, Gillen D, Javaid B et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006; 81: 704-710
16. Williams JW, Javaid B, Kadambi PV et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005; 352: 1157-1158
17. Andrei G, Snoeck R, Vandeputte M, De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997; 41: 587-593
18. De Luca A, Giancola ML, Ammassari A et al. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy. AIDS 2000; 14: F117-F121
19. Lim WH, Mathew TH, Cooper JE, Bowden S, Russ GR. Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients. Nephrology 2003; 8: 318-323
20. Bjorang O, Tveitan H, Midtvedt K, Broch LU, Scott H, Andresen PA. Treatment of polyomavirus infection with cidofovir in a renal transplant recipient. Nephrol Dial Transplant 2002; 17: 2023-2025
21. Kadambi PV, Josephson MA, Williams J et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003; 3: 186-191
22. Vats A, Shapiro R, Randhawa PS et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 105-112
23. Keller LS, Peh CA, Nolan J, Bannister KM, Clarkson AR, Faull RJ. BK transplant nephropathy successfully treated with cidofovir. Nephrol Dial Transplant 2003; 18: 1013-1014
24. Trofe J, Roy-Chaudhury P, Gordon J et al. Outcomes of patients with rejection post-polyomavirus nephropathy. Transplant Proc 2005; 37: 942-944
25. Casadei DH, Rial MC, Opelz G et al. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2001; 71: 53-58
26. Puliyanda D, Radha RK, Amet N et al. IVIG contains antibodies reactive with polyoma BK virus and may represent a therapeutic option for BK nephropathy. Am J Transplant 2003; 3 [Suppl 4]: 393
27. Sener A, House AA, Jevnikar AM et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients. Transplantation 2006; 81: 117-120
28. Funk GA, Steiger J, Hans HH. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 2006; 193: 80-87
29. Lipshutz GS, Flechner SM, Govani MV, Vincenti F. BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen. Am J Transplant 2004; 4: 2132-2134